Literature DB >> 35496973

Donor Characteristics Predict the Success of Allogeneic Hematopoietic Stem Cell Transplantation in Thalassemia Major: A Single-Center Analysis of 250 Patients.

Revathi Raj1, Venkateswaran Vellaichamy Swaminathan1, Satishkumar Meena1, Harika Varla1, Rumesh Chandar1, Balasubramaniam Ramakrishnan2, Mythyly Vaikuntham3, Venkadadesikalu Maljetty3, Ramya Uppuluri1.   

Abstract

Introduction We present data on the impact of donor characteristics in a uniform cohort of children who underwent hematopoietic stem cell transplantation (HSCT) for thalassemia major. Patients and methods We performed a retrospective study in children undergoing matched related (MRD) or unrelated (MUD) HSCT from January 2009 to December 2019. Results We analyzed data on 250 patients (age seven months-19 years), MRD n = 187, MUD n = 63. We documented sex mismatch in 44% of HSCTs. The graft rejection rate was 3.7%; all had a sex mismatched HSCT (P value = 0.001). Graft versus host disease (GVHD) was higher when donors were above two years as compared to less than two years (23%vs.6.5%, P value = 0.006), with higher rates of mixed chimerism when donors were < two years at 33.3%vs.8.3% in > two years (P value = 0.0001). Mortality and GVHD were higher in the MUD group as compared to the MRD group (15%vs.5%, P value = 0.009; 42.9%vs. 23.4%, P value = 0.0001 respectively). Overall survival was 92.8% with a median follow up of 5.4 years, and was superior in MRD versus MUD group (9.4 years versus 4.8 years P = 0.008). Conclusion The risk of graft rejection was higher with donor-recipient sex mismatch; while initial mortality and chronic GVHD was higher with MUD HSCT. © Indian Society of Hematology and Blood Transfusion 2021.

Entities:  

Keywords:  Donor age; HSCT; Mixed chimerism; Sex mismatch; Thalassemia major

Year:  2021        PMID: 35496973      PMCID: PMC9001767          DOI: 10.1007/s12288-021-01487-w

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

1.  Donor and recipient sex in allogeneic stem cell transplantation: what really matters.

Authors:  Haesook T Kim; Mei-Jie Zhang; Ann E Woolfrey; Andrew St Martin; Junfang Chen; Wael Saber; Miguel-Angel Perales; Philippe Armand; Mary Eapen
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

2.  Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation.

Authors:  Sayeh Parkhideh; Rouzbeh Chegeni; Mahshid Mehdizadeh; Elham Roshandel; Farzaneh Tavakoli; Abbas Hajifathali
Journal:  Transfus Apher Sci       Date:  2019-12-13       Impact factor: 1.764

3.  Related and unrelated donor transplantation for β-thalassemia major: results of an international survey.

Authors:  Chunfu Li; Vikram Mathews; Soyoung Kim; Biju George; Kyle Hebert; Hua Jiang; Changgang Li; Yiping Zhu; Daniel A Keesler; Jaap Jan Boelens; Christopher C Dvorak; Rajni Agarwal; Jeffery J Auletta; Rakesh K Goyal; Rabi Hanna; Kimberly Kasow; Shalini Shenoy; Angela R Smith; Mark C Walters; Mary Eapen
Journal:  Blood Adv       Date:  2019-09-10

4.  Safety and efficacy of fresh whole blood donor lymphocyte infusion in children.

Authors:  Venkateswaran Vellaichamy Swaminathan; Ramya Uppuluri; Shivani Patel; Meena Sivashankaran; Nikila Ravichandran; Kesavan Melarcode Ramanan; Balasubramaniam Ramakrishnan; Lakshman Vaidhyanathan; Revathi Raj
Journal:  Bone Marrow Transplant       Date:  2019-05-31       Impact factor: 5.483

5.  Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation.

Authors:  Rafiye Ciftciler; Hakan Goker; Yahya Buyukasık; Tulay Karaagac; Salih Aksu; Fatma Tekin; Haluk Demiroglu
Journal:  Transfus Apher Sci       Date:  2019-07-10       Impact factor: 1.764

6.  Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.

Authors:  Hideki Nakasone; Mats Remberger; Lu Tian; Petter Brodin; Bita Sahaf; Fang Wu; Jonas Mattsson; Robert Lowsky; Robert Negrin; David B Miklos; Everett Meyer
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

7.  A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation.

Authors:  Vikram Mathews; Biju George; Uday Deotare; Kavitha M Lakshmi; Auro Viswabandya; Dolly Daniel; Mammen Chandy; Alok Srivastava
Journal:  Biol Blood Marrow Transplant       Date:  2007-06-22       Impact factor: 5.742

8.  Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.

Authors:  Venkateswaran Vellaichamy Swaminathan; Ramya Uppuluri; Shivani Patel; Nikila Ravichandran; Kesavan Melarcode Ramanan; Lakshman Vaidhyanathan; Balasubramaniam Ramakrishnan; Indira Jayakumar; Revathi Raj
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-19       Impact factor: 5.742

9.  Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders-A Perspective.

Authors:  Clare Zimmerman; Shalini Shenoy
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

10.  Outcome of donor and recipient sex match versus mismatch in stem cell transplant procedure.

Authors:  Natasha Ali; Hayat Ullah; Mohammad Usman Shaikh; Salman Naseem Adil
Journal:  Int J Hematol Oncol       Date:  2019-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.